Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why CRISPR Therapeutics Stock Is Jumping Today


Shares of CRISPR Therapeutics (NASDAQ: CRSP) were jumping 9.1% as of 11:31 a.m. ET on Tuesday after rising as much as 13% earlier in the day. The nice gain came after the company provided its second-quarter update on Monday following the market close.

CRISPR Therapeutics reported second-quarter revenue of $70 million. It posted a net loss of $77.7 million, or $0.98 per share. Both results topped consensus estimates.

Two analysts also issued positive updates after the results were announced. Needham reiterated coverage of the stock with a buy recommendation. Credit Suisse's Richard Law reiterated a neutral rating for the gene-editing stock but increased his price target from $62 to $63. 

Continue reading


Source Fool.com

Like: 0
Share

Comments